News Focus
News Focus
icon url

kris_kade

08/23/12 7:49 PM

#2892 RE: OldBen #2891

Day trading Clsn might be costly on two accounts. For me personally it will throw me into much higher tax bracket as well as loose out on a potential big pay off. Chasing a stock which has strong fundies like Clsn, one ends up buying higher for a short ride without knowing for sure where the lows are.
icon url

biomanbaba

08/23/12 8:14 PM

#2894 RE: OldBen #2891

Ben are you shiting us here

"[Any first time drug runs a higher risk of rejection."/b]

Doxorubicin is an old drug approved for YEARS
http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000614/

the new thing about THERMODOX is encapulation and release thru Ablation...using the Caveat in THIS SITUATION is for lack of a
better description Bovine Excrement
icon url

No-dough-go

08/23/12 8:37 PM

#2899 RE: OldBen #2891

A lot of times the benefit of attempting to trade peaks and valleys can be somewhat illusory. Especially if one waits for buy and sell side confirmations which, in effect, reduces the peaks and valleys. This trading strategy gives one less overall exposure ASSUMING, they do it VERY well, however, many "traders" find that their ROI would have been better had they just held through the ups and downs when the stock's overall and long-term performance has been good but that mentality increases liquidity and as a result, actually helps the long-term stock price so I'm all for it.